Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
Bayer and Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics […]
Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application for REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease
Otsuka Pharmaceutical and Lundbeck announce the U.S. Food and Drug Administration (FDA) has approved the supplemental New […]
RQM+ Acquires Libra Medical
RQM+, the world’s leading MedTech service provider, has announced the acquisition of Libra Medical, a […]
Servier Receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma
Servier, a global pharmaceutical group, today announced that the European Commission (EC) has approved Tibsovo […]
UCB and Ariceum Therapeutics Sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment […]
Nelson Fernandes, CerTest Biotec, on Diagnostic Products
We caught up with Nelson Fernandes, the Managing Director at CerTest Biotec, at 33rd ECCMID […]
Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
Healthy.io, the global leader in transforming the smartphone camera into a medical device, today announced […]
BRIM Plans to launch a New Funding Round to Accelerate Late-Stage Clinical Trial and Initiate a New Phase 2 Trial for Orphan Drug BRM424
BRIM Biotechnology, a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint […]
David Jenkins, University Hospitals of Leicester, Discussing Antimicrobial Chemotherapy
In the video, David Jenkins, a consultant medical microbiologist from the University Hospitals of Leicester, […]
Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors
Voyager Therapeutics, a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more